Sponsor:
Olema Pharmaceuticals, Inc.
Code:
NCT05508906
Conditions
Metastatic Breast Cancer
Advanced Breast Cancer
ER-positive Breast Cancer
HER2-negative Breast Cancer
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OP-1250
Ribociclib
Alpelisib
Everolimus
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Olema Pharmaceuticals, Inc. on 2024-10-03.